Who is sponsoring NCT05126446?

NCT05126446 is sponsored by Lifetech Scientific (Shenzhen) Co., Ltd..

What condition does NCT05126446 study?

NCT05126446 studies Aortic Dissection.

Is NCT05126446 still recruiting?

NCT05126446 is currently active, enrolled. Last updated 23 July 2024.

Last reviewed 2024-07-23 · How we verify

NCT05126446

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

the Aorta Arch Stent Graft System Combined With the Endovascular Needle System in Situ Fenestration

Active, enrolled NA Last updated 23 July 2024

What this trial tests

NA trial testing the Aorta Arch Stent Graft System combined with the Endovascular Needle System in Aortic Dissection in 120 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

25 July 2021

Primary endpoint
30 October 2027

30 March 2028

Quick facts

Lead sponsor	Lifetech Scientific (Shenzhen) Co., Ltd.
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	120
Start date	25 July 2021
Primary completion	30 October 2027
Estimated completion	30 March 2028
Sites	1 location across China

Drugs / interventions tested

the Aorta Arch Stent Graft System combined with the Endovascular Needle System

Conditions studied

Aortic Dissection — all drugs for Aortic Dissection →

Sponsor

Lifetech Scientific (Shenzhen) Co., Ltd. — full company profile →

Who can join

Adults 18 to 80, any sex, with Aortic Dissection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective, multi-center, single-group target value method to evaluate the safety and effectiveness of the Aorta Arch Stent Graft System combined with the Endovascular Needle System in situ fenestration technology in the treatment of aortic dissection involving the aortic arch

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

First-in-Human Implantation of Gutter-Free Design Stent-Graft in <i>in situ</i> Fenestration TEVAR for Aortic Arch Pathology.
Li X, Shu C, Wang L, Li Q, et al · · 2022 · cited 1× · PMID 35845060 · DOI 10.3389/fcvm.2022.911689
Early Results of a Single-Center Prospective Clinical Trial: In Situ Fenestration System for Aortic Dissection.
Tan Y, Chen W, Li Z, Xu H, et al · · 2025 · PMID 40289333 · DOI 10.1177/15385744251330013

Verify or expand the search:

Other recruiting trials for Aortic Dissection

Currently open trials in the same condition.

NCT06550986 — False Lumen Treatment for Prevention of Aortic Growth Using Shape Memory Polymer - First-in-Human Study · NA · recruiting
NCT06968806 — Study on Ketorolac for Improving Outcomes and Prognosis in Patients With Stanford Type A Aortic Dissection · Phase 3 · recruiting
NCT06827990 — GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections · NA · recruiting
NCT06915545 — Study on the Aortic Arch Single Branch Stent Graft System · NA · recruiting
NCT07117825 — Aortic Dissection fAlse enlarGement radIomics predictiOn · active not recruiting

Other Lifetech Scientific (Shenzhen) Co., Ltd. trials

Trials by the same sponsor.

NCT07385599 — FIM Study of the LAmbre™ II LAA Occluder in Non-Valvular AF Patients · NA · active not recruiting
NCT06915545 — Study on the Aortic Arch Single Branch Stent Graft System · NA · recruiting
NCT06849635 — Cera™ ASD Occluder Post-Market Clinical Follow-Up Study · recruiting
NCT06700174 — Lifetech AcuMark™ Sizing Balloon Post-Market Clinical Follow-up Study · recruiting
NCT06520774 — Concave Supra-arch Branched Stent-Graft System for Endovascular Treatment of Aortic Arch Diseases · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05126446 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Lifetech Scientific (Shenzhen) Co., Ltd.
Last refreshed: 23 July 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05126446.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing